TITLE

LUNG ALERT

PUB. DATE
May 2005
SOURCE
Thorax;May2005, Vol. 60 Issue 5, p432
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a novel mechanism of emphysema pathogenesis in Z-Alpha-1-antitrypsin (AT) homozygotes. AT is the predominant proteinase inhibitor in the lung. There are many abnormal variants of AT and the Z form is one of the most frequently encountered. Z-AT is prone to polymerization and the polymeric form aggregates in the liver, causing a plasma deficiency, while monomeric Z-AT is a less effective proteinase inhibitor than normal AT. This quantitative and functional deficiency exposes the lung to damaging proteinases such as neutrophil elastase which results in emphysema.
ACCESSION #
17105980

 

Related Articles

  • Alpha-1 -Antitrypsin Deficiency: A Case of a Two-year Old Boy with Inherited Disease. Petlichkovski, Aleksandar; Peova, Sonja; Trajkov, Dejan; Arsov, Todor; Strezova, Ana; Hristomanova, Slavica; Djulejic, Eli; Petrov, Jordan; Spiroski, Mirko // Macedonian Journal of Medical Sciences;9/15/2008, Vol. 1 Issue 1, p59 

    Alpha-1-antitrypsin (AAT) is a protease inhibitor which plays an important role of protector of the lung tissues against the proteolytic effect of elastase secreted from neutrophils. Its deficiency is associated with liver disease in children and emphysema in adults. So far, more than 75...

  • Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies. Turner, Alice M. // BioDrugs;Dec2013, Vol. 27 Issue 6, p547 

    Alpha 1 antitrypsin deficiency (AATD) is a rare cause of chronic obstructive pulmonary disease. The lung disease is thought to be caused primarily by a lack of effective protection against the harmful effects of neutrophil elastase due to the low AAT levels in the lung. Patients may also develop...

  • Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD? Godoy, Irma // Jornal Brasileiro de Pneumologia;set/out2016, Vol. 42 Issue 5, p307 

    No abstract available.

  • PROTEINASE 3 ACTIVITY IN SPUTUM FROM ALPHA-1-ANTITRYPSIN DEFICIENT SUBJECTS. Sinden, N. J.; Ungurs, M.; Edgar, R.; Bharadwa, P.; Stockley, R. A. // Thorax;Dec2011 Supplement, pA37 

    Introduction Tissue destruction in emphysema is widely believed to result from an imbalance between serine proteinases and their inhibitors, the antiproteinases. Previous work has studied the role of neutrophil elastase (NE), but there are few studies of proteinase 3 (PR3). PR3 is released from...

  • Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults. Ngo, Leock Y.; Haeberle, Adam; Dyck-Jones, Jacqueline; Gelmont, David; Yel, Leman // Open Access Journal of Clinical Trials;2014, Vol. 6, p55 

    Purpose: Alpha1-proteinase inhibitor (A1PI) is indicated for chronic augmentation therapy in adults with emphysema due to congenital deficiency of A1PI. An intravenous infusion rate of 0.04 mL/kg/minute is currently recommended for the A1PI product, Glassia®. This randomized, placebo-masked,...

  • 3D CRYO-ELECTRON MICROSCOPIC ANALYSIS OF THE DISEASE MECHANISM OF α1-ANTITRYPSIN DEFICIENCY. Gooptu, B.; Chaban, Y.; Irving, J. A.; Clare, D. K.; Lomas, D. A.; Orlova, E.; Saibil, H. R. // Thorax;Dec2011 Supplement, pA115 

    α1-antitrypsin deficiency is characterised by predispositions to liver disease and severe, early-onset emphysema. It is caused by point mutations that destabilise the molecular structure of α1-antitrypsin, leading it to self-associate into chains known as polymers. Polymerisation abolishes...

  • REDUCING INTRACELLULAR AGGREGATION AND IMPROVING THE SECRETION OF Z ALPHA-1 ANTITRYPSIN. Alam, S.; Wang, J.; Janciauskiene, S.; Mahadeva, R. // Thorax;Dec2011 Supplement, pA25 

    The Z variant (Glu342Lys) of α1-antitrypsin (AT) is one of the serpinopathies; it polymerises and accumulates in the hepatocyte endoplasmic reticulum (ER) resulting in neonatal hepatitis and liver cirrhosis. The secretory defect leaves the lungs vulnerable to elastolysis and early-onset...

  • Pathophysiology of Hereditary Emphysema. Stevens, Paul M.; Hnilica, Violette S.; Johnson, Philip C.; Bell, Robert L. // Annals of Internal Medicine;May71, Vol. 74 Issue 5, p672 

    Discusses a study which examined the relationship between alpha[sub 1]-antitrypsin deficiency and the development of emphysema. Materials and methodology; Clinical manifestations of chronic obstructive pulmonary disease; Findings of radioxenon studies on patients with alpha[sub 1]-antitrypsin...

  • POLYMERS OF Z α1-ANTITRYPSIN ARE ASSOCIATED WITH PULMONARY INFECTION POST LUNG TRANSPLANTATION. Santhanakrishnan, K.; Alam, S.; Parmar, J.; Mahadeva, R. // Thorax;Dec2011 Supplement, pA27 

    Z antitrypsin (Z-AT) polymerises in the liver and is associated with early onset emphysema. Polymers of Z-ATare not only inactivate as antiproteinases, but also act as a pro-inflammatory stimulus. We studied patients with emphysema post lung transplantation, with and without AT deficiency, to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics